Chih-Yuan Ma

Title: Chih-Yuan Ma: Innovator in Wound Healing and CD14-Mediated Disorders

Introduction

Chih-Yuan Ma is a notable inventor based in Tainan, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the areas of wound healing and the treatment of CD14-mediated disorders. With a total of 2 patents, his work has the potential to impact many lives.

Latest Patents

Chih-Yuan Ma's latest patents include a composition for use in promoting wound healing. This pharmaceutical composition is designed to accelerate the closure of open wounds in subjects in need. It comprises a therapeutically effective amount of a recombinant polypeptide with an amino acid sequence that is at least 80% identical to a specified sequence, along with a pharmaceutically acceptable vehicle. Another significant patent involves methods for treating CD14-mediated disorders. This method focuses on blocking and inhibiting CD14 function and cellular responses, utilizing a recombinant protein that does not include a lectin-like domain of human thrombomodulin.

Career Highlights

Throughout his career, Chih-Yuan Ma has worked with various companies, including Blue Blood Biotech Corp. His innovative approaches and research have positioned him as a key figure in his field.

Collaborations

Chih-Yuan Ma has collaborated with notable coworkers such as Guey-Yueh Shi and Hua-Lin Wu. Their combined expertise has contributed to the advancement of their research and innovations.

Conclusion

Chih-Yuan Ma's contributions to pharmaceutical innovations, particularly in wound healing and CD14-mediated disorders, highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments.